Discovery, Synthesis And Evaluation Of Oxynitidine Derivatives As Dual Inhibitors Of DNA Topoisomerase IB (TOP1) And Tyrosyl-DNA Phosphodiesterase 1 (TDP1), And Potential Antitumor Agents

Technology
E-181-2018
Patent ID
E-181-2018-0-CN-01
Country
CN
Application Type
ORD
Patent Status
Pending
Patent Number
 
Publication Number
CN110759963A
Application Number
201810827467.1
IC
NCI
Date Filed
Date Issued
 
Patent PDF
 
Related Technologies
TAB-4079     Oxynitidine Derivatives Useful as Inhibitors of Topoisomerase IB (TOP1) and Tyrosyl-DNA Phosphodiesterase 1 (TDP1) for Treating Cancer